Continuation in Treatment and Maintenance of Custody of Newborns After Delivery in Women With Opioid Use Disorder.
Journal
Journal of addiction medicine
ISSN: 1935-3227
Titre abrégé: J Addict Med
Pays: Netherlands
ID NLM: 101306759
Informations de publication
Date de publication:
Historique:
pubmed:
5
4
2019
medline:
17
6
2021
entrez:
5
4
2019
Statut:
ppublish
Résumé
To identify variables associated with continuation in treatment and maintenance of custody after pregnancies in women with opioid use disorder (OUD). The medical records of pregnant women with documented OUD from 2011 to 2018 and with at least 6 months follow-up postpartum were retrospectively reviewed. Via multivariate analysis, women on opioid maintenance therapy (OMT) were more likely to continue in treatment and maintain custody, whereas women enrolled in a residential treatment program during pregnancy were less likely to continue in treatment or maintain custody. Women who continued in treatment were significantly more likely to maintain custody of their children than those who did not. Continuation in treatment and maintenance of custody were closely related. Care providers should attempt to improve both outcomes.
Identifiants
pubmed: 30946092
doi: 10.1097/ADM.0000000000000534
pii: 01271255-202004000-00006
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
119-125Références
Canfield M, Radcliffe P, Marlow S, et al. Maternal substance use and child protection: A rapid evidence assessment of factors associated with loss of child care. Child Abuse Negl 2017; 70:11–27.
Chapman SL, Wu LT. Postpartum substance use and depressive symptoms: A review. Women Health 2013; 53:479–503.
Clark HW. Residential substance abuse treatment for pregnant and postpartum women and their children: treatment and policy implications. Child Welfare 2001; 80:179–198.
Fischer G, Eder H, Jagsch R, et al. Maintenance therapy with synthetic opioids within a multidisciplinary program - a stabilizing necessity for pregnant opioid dependent women. Arch Womens Ment Health 1998; 1:109–116.
Gilchrist G, Taylor A. Drug-using mothers: Factors associated with retaining care of their children. Drug Alcohol Rev 2009; 28:175–185.
Grella CE, Hser YI, Huang YC. Mothers in substance abuse treatment: Differences in characteristics based on involvement with child welfare services. Child Abuse Negl 2006; 30:55–73.
Kendler KS, Ohlsson H, Svikis DS, et al. The protective effect of pregnancy on risk for drug abuse: a population, co-relative, co-spouse, and within-individual analysis. Am J Psychiatry 2017; 174:954–962.
Lundgren LM, Schilling RF, Fitzgerald T, et al. Parental status of women injection drug users and entry to methadone maintenance. Subst Use Misuse 2003; 38:1109–1131.
McCann KJ, Twomey JE, Caldwell D, et al. Services used by perinatal substance-users with child welfare involvement: A descriptive study. Harm Reduct J 2010; 7:19.
Meier PS, Donmall MC, McElduff P. Characteristics of drug users who do or do not have care of their children. Addiction 2004; 99:955–961.
Meyer M, Benvenuto A, Howard D, et al. Development of a substance abuse program for opioid-dependent nonurban pregnant women improves outcome. J Addict Med 2012; 6:124–130.
O’Connor AB, Uhler B, O’Brien LM, et al. Predictors of treatment retention in postpartum women prescribed buprenorphine during pregnancy. J Subst Abuse Treat 2018; 86:26–29.
O’Donnell M, Nassar N, Leonard H, et al. Increasing prevalence of neonatal withdrawal syndrome: population study of maternal factors and child protection involvement. Pediatrics 2009; 123:e614–e621.
Sarkola T, Kahila H, Gissler M, et al. Risk factors for out-of-home custody child care among families with alcohol and substance abuse problems. Acta Paediatr 2007; 96:1571–1576.
Taplin S, Mattick RP. Mothers in methadone treatment and their involvement with the child protection system: A replication and extension study. Child Abuse Neglect 2013; 37:500–510.
Wilder CM, Hosta D, Winhusen T. Association of methadone dose with substance use and treatment retention in pregnant and postpartum women with opioid use disorder. J Subst Abuse Treat 2017; 80:33–36.
Wilder C, Lewis D, Winhusen T. Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder. Drug Alcohol Depend 2015; 149:225–231.
Wobie K, Eyler FD, Conlon M, et al. Women and children in residential treatment: Outcomes for mothers and their infants. J Drug Iss 1997; 27:585–606.
Wright TE, Schuetter R, Fombonne E, et al. Implementation and evaluation of a harm-reduction model for clinical care of substance using pregnant women. Harm Reduct J 2012; 9: 5-7517-9-5.